Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple glue stop Post-Surgery fluid pockets in breast cancer patients?

NCT ID NCT01742975

First seen Oct 31, 2025 · Last updated Jun 22, 2026 · Updated 43 times

Summary

This study tested whether a surgical glue called Ifabond can reduce seroma—painful fluid collections—after breast cancer surgery. 104 women having partial mastectomy with or without lymph node removal were randomly assigned to receive standard surgery plus the glue or standard surgery alone. The main goal was to measure fluid volume and ultrasound findings at 15 and 30 days after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre de Chirurgie Gynecologique Et Des Maladies Du Sein

    Grenoble, Auvergne-Rhône-Alpes, 38000, France

  • Hôpital Euroépen Marseille

    Marseille, PACA, 13003, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ifabond (surgical glue)

What this could lead to

If it works, this could reduce painful fluid collections after breast cancer surgery, lowering the need for needle drainage and improving comfort.

What could go wrong

This is a small, completed study with 104 patients. The glue may not significantly reduce seroma, and some people may be allergic to cyanoacrylate.

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm lymphocele

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.